Quest Diagnostics (NYSE: DGX), a provider of diagnostic information services, announced on Wednesday its quarterly cash dividend.
The company has declared dividend of USD0.56 per share.
The dividend will be paid to shareholders of record at 20 January 2021 on 3 February 2021.
The company's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviours and improve health care management.
Abbott announces quarterly common dividend
CVS Health declares unchanged quarterly dividend
ALK partners with GenSci to expand allergy immunotherapy market in China
Curatis secures Swiss distribution deal with Phoenix Labs
Innocan Pharma reports 'positive swing' in operating profitability for first half of 2025
Wolters Kluwer boosts medical research efficiency with Ovid AI summarisation
European Commission approves Gilead's twice-yearly HIV prevention injection Yeytuo
Essa Pharma clarifies Nasdaq due bill trading period for cash distribution
Advanz Pharma and Alvotech secure European approval for aflibercept biosimilar Mynzepli
Heron Therapeutics announces tax benefits preservation plan adoption